|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| OPERATING ACTIVITIES: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash from operating activities: | |||||
| Loss on equity method investment | |||||
| Revaluation gain on previously held equity method investment | |||||
| Impairment of operating lease right-of-use assets | |||||
| Loss on disposals of equipment, software and other assets | |||||
| Losses and impairments related to divestitures | |||||
| Loss (gain) related to warrant liabilities, net | |||||
| Change in TRA Liability | |||||
| Depreciation and amortization | |||||
| Provision for deferred taxes | |||||
| Share-based compensation expense | |||||
| Non-cash lease expense | |||||
| Net investment gains | |||||
| (Accretion) amortization of discount and premium, net | |||||
| Other | |||||
| Changes in assets and liabilities: | |||||
| Accounts, premiums and commissions receivable | |||||
| Deferred acquisition costs, net | |||||
| Reinsurance recoverables | |||||
| Prepaid reinsurance premiums | |||||
| Advance premiums and due to insurers | |||||
| Losses payable and provision for unpaid losses and loss adjustment expenses | |||||
| Increase (Decrease) in Liability for Claims and Claims Adjustment Expense Reserve | |||||
| Due to insurers | |||||
| Advanced premiums | |||||
| Unearned premiums | |||||
| Operating lease assets and liabilities | |||||
| Ceding commissions payable | |||||
| Other assets and liabilities, net | |||||
| Net Cash Provided by Operating Activities | |||||
| INVESTING ACTIVITIES: | |||||
| Capital expenditures | |||||
| Acquisitions, net of cash acquired, and other investments | |||||
| Purchase of previously held equity method investment | |||||
| Issuance of note receivable to previously held equity method investment | |||||
| Issuance of notes receivable | |||||
| Collection of notes receivable | |||||
| Purchases of fixed maturity securities | |||||
| Proceeds from sales of fixed maturity securities | |||||
| Purchases of equity securities | |||||
| Proceeds from maturities of fixed maturity securities | |||||
| Other investing activities | |||||
| Net Cash Used in Investing Activities | |||||
| FINANCING ACTIVITIES: | |||||
| Payments on long-term debt | |||||
| Proceeds from long-term debt, net of issuance costs | |||||
| Proceeds from Issuance of Preferred Stock and Preference Stock | |||||
| Contribution from non-controlling interest | |||||
| Distributions | |||||
| Cash received in Business Combination | |||||
| Cash consideration to HHC at closing of Business Combination | |||||
| Payment of capitalized transaction costs | |||||
| Proceeds from issuance of common stock under employee stock purchase plan | |||||
| Distributions paid to non-controlling interest unit holders | |||||
| Payment of Series A Convertible Preferred Stock dividends | |||||
| Funding of TRA Liability payments | |||||
| Funding of employee tax obligations upon vesting of share-based payments | |||||
| Other financing activities | |||||
| Net Cash Provided by (Used in) Financing Activities | |||||
| Effect of exchange rate changes on cash and cash equivalents and restricted cash and cash equivalents | |||||
| Change in cash and cash equivalents and restricted cash and cash equivalents | |||||
| Beginning cash and cash equivalents and restricted cash and cash equivalents | |||||
| Ending cash and cash equivalents and restricted cash and cash equivalents | |||||
| Purchase of property, equipment and software | |||||
| Acquisitions | |||||
| Total acquisitions | |||||
| Interest | |||||
| Income taxes | |||||
| Cash and cash equivalents | |||||
| Restricted cash and cash equivalents | |||||
Loading...